- Home
- BMY vs NU Comparison
BMY vs NU Comparison
Compare BMY & NU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | NU |
|---|---|---|
| Founded | 1887 | 2013 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0B | 77.0B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BMY | NU |
|---|---|---|
| Price | $50.82 | $16.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $55.58 | $17.60 |
| AVG Volume (30 Days) | 15.1M | ★ 40.7M |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | ★ 4.80% | N/A |
| EPS Growth | N/A | ★ 41.55 |
| EPS | ★ 2.97 | 0.52 |
| Revenue | ★ $48,034,000,000.00 | $6,360,698,000.00 |
| Revenue This Year | $0.23 | $172.18 |
| Revenue Next Year | N/A | $24.47 |
| P/E Ratio | ★ $17.39 | $32.22 |
| Revenue Growth | 1.26 | ★ 20.40 |
| 52 Week Low | $42.52 | $9.01 |
| 52 Week High | $63.33 | $17.84 |
Technical Indicators
Market Signals| Indicator | BMY | NU |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 52.25 |
| Support Level | $48.22 | $17.29 |
| Resistance Level | $52.51 | $17.82 |
| Average True Range (ATR) | 1.13 | 0.56 |
| MACD | 0.29 | -0.01 |
| Stochastic Oscillator | 77.92 | 53.45 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About NU Nu Holdings Ltd.
Nu Holdings Ltd provides digital banking services. It offers several financial services such as Credit cards, Personal accounts, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.